<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">818010</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2021.818010</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Multi-Omics Technologies for Optimizing Synthetic Biomanufacturing</article-title>
<alt-title alt-title-type="left-running-head">Kim et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Editorial: Multi-Omics Technologies in Biomanufacturing</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kim</surname>
<given-names>Young-Mo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/126581/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Petzold</surname>
<given-names>Christopher J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/24084/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerkhoven</surname>
<given-names>Eduard J.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/337604/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Scott E.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/750937/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Integrative Omics Group, Biological Sciences Division, Pacific Northwest National Laboratory, <addr-line>Richland</addr-line>, <addr-line>WA</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Department of Energy, Agile BioFoundry, <addr-line>Emeryville</addr-line>, <addr-line>CA</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, <addr-line>Berkeley</addr-line>, <addr-line>CA</addr-line>, <country>United&#x20;States</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Department of Biology and Biological Engineering, Chalmers University of Technology, <addr-line>Gothenburg</addr-line>, <country>Sweden</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>Functional and Systems Biology Group, Environmental Molecular Sciences Division, Pacific Northwest National Laboratory, <addr-line>Richland</addr-line>, <addr-line>WA</addr-line>, <country>United&#x20;States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/59532/overview">Jean Marie Fran&#xe7;ois</ext-link>, Institut Biotechnologique de Toulouse (INSA), France</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Young-Mo Kim, <email>young-mo.kim@pnnl.gov</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Synthetic Biology, a section of the journal Frontiers in Bioengineering and Biotechnology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>818010</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>11</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Kim, Petzold, Kerkhoven and Baker.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Kim, Petzold, Kerkhoven and Baker</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/researchtopic/10828" ext-link-type="uri">Editorial on the Research Topic<article-title>Multi-Omics Technologies for Optimizing Synthetic Biomanufacturing</article-title>
</related-article>
<kwd-group>
<kwd>biomanufacturing</kwd>
<kwd>multi-omics analysis</kwd>
<kwd>synthetic biology</kwd>
<kwd>DBTL cycle</kwd>
<kwd>metabolic engineering</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Industrial manufacturing endures as an essential human activity yielding a variety of useful products; it plays a significant role in the global economy with huge impacts in everyday life. However, the manufacturing process requires consumption of various raw materials (especially petroleum derivatives), generates a variety of harmful waste products, causes pollution, and is energetically inefficient. Biological manufacturing from sustainable, affordable, and scalable feedstocks potentially enables the displacement of the entire portfolio of currently available products produced by industrial processes, enabling the manufacturing of renewable and eco-friendly products (<xref ref-type="bibr" rid="B1">Clomburg et&#x20;al., 2017</xref>). Thus, successful development of a robust biomanufacturing strategy and technology platform, based on the latest advances in synthetic biology and chemical catalysis, will decrease both the cost and production time compared with previous manufacturing processes. Development of biomanufacturing processes using a synthetic biology platform requires the multidisciplinary efforts of science and engineering fields including molecular biology, microbiology, genetic engineering, informatics, metabolic modeling and chemical or process engineering (<xref ref-type="bibr" rid="B2">El Karoui et&#x20;al., 2019</xref>).</p>
<p>In this research topic, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.613307/full">Amer and Baidoo</ext-link> discussed the importance of using multi-omic analytical approaches to monitor and improve the biomanufacturing process. These approaches include genomics, transcriptomics, proteomics, metabolomics and fluxomics (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). The multi-omics data acquired from the biomanufacturing process not only provides potential solutions to low production efficiency by identifying underlying metabolic bottlenecks or pathway sinks, but also guides the understanding of how these modified biological systems function. Furthermore, such multi-omics technologies are constantly innovated and improved to expand molecular detection coverage, obtain data with increased accuracy by using new or novel analytical instruments, achieve better computational algorithms, and create wider and deeper databases to support a growing variety of biological host systems. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.612893/full">Roy et&#x20;al.</ext-link> described a combined computational tool to optimize the DBTL (Design-Build-Test-Learn) cycle in biomanufacturing process by collecting, visualizing, and utilizing large multi-omics datasets from various biological systems and emphasized their importance in the following metabolic engineering processes with machine learning approaches.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic view of multi-omics application to biomanufacturing process. Improvement of each technology will enhance the measurement coverage and accuracy in future applications.</p>
</caption>
<graphic xlink:href="fbioe-09-818010-g001.tif"/>
</fig>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2020.603488/full">Gao et&#x20;al.</ext-link> compared microflow and nanoflow liquid chromatography-selected reaction monitoring (LC-SRM) methods for analysis of hundreds of targeted peptides associated with 132 proteins in major pathways of <italic>Pseudomonas putida,</italic> a versatile bacterial host for production of bioproducts and biofuels <italic>via</italic> metabolic engineering. The increased throughput and accuracy of protein measurement will not only reduce the DBTL cycle time in future applications, but is, in addition, easily applied to other biomanufacturing host organisms.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2020.539902/full">Fletcher and Baetz</ext-link> reviewed the toxicity of phenolic compounds which are produced from pretreatment or hydrolysis of natural lignocellulosic biomass based on functional genomics and transcriptomics approaches, especially to the important model organism and industrial bioproduction host strain, <italic>Saccharomyces cerevisiae</italic>. Information regarding physiological tolerances of toxic phenolic compounds may be applied and evaluated in other host strains for future improvement. In that regard, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2020.00772/full">Garcia et&#x20;al.</ext-link> developed the genome-scale metabolic model of <italic>Clostridium thermocellum</italic> for efficient conversion of lignocellulosic biomass which has unique preference for its anaerobic and thermophilic growth attributes. This model will provide a useful tool to understand physiological and metabolic parameters associated with potential future biomanufacturing process.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2020.01008/full">Pinheiro et&#x20;al.</ext-link> studied a xylose metabolism by <italic>Rhodosporidium toruloides</italic>, an oleaginous yeast with significant emerging potential in industrial applications, using a detailed physiological characterization interpreted with absolute proteomics and genome scale metabolic models. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2020.612832/full">Kim et&#x20;al.</ext-link> performed a multi-omics analysis on <italic>R. toruloides</italic> and the transcriptomics, proteomics, metabolomics and RB-TDNA sequencing data improved the current genome-scale model to make it a more exhaustive and accurate metabolic network&#x20;model.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.603832/full">Pomraning et&#x20;al.</ext-link> integrated high-throughput proteomics and metabolomics data as part of a DBTL cycle focused on improving production efficiency of 3-hydroxypropionic acid (3HP) in engineered <italic>Aspergillus pseudoterreus</italic> strains. This was the first report of 3HP production in a filamentous fungus amenable to industry-level biomanufacturing of organic acids at high titer and low pH. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.644216/full">Chroumpi et&#x20;al.</ext-link> studied another filamentous fungus <italic>Aspergillus niger</italic> for better understanding of pentose catabolic pathways by deletion of the key genes. The high-throughput multi-omics data (i.e.,&#x20;transcriptome, metabolome and proteome) generated on the mutant strains revealed that these genes are critical for metabolic pathways but not as critical for growth of <italic>A. niger</italic> on more complex biomass substrates, which raises fundamental questions on nutrient acquisition during growth on various carbon sources.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.707749/full">Wu et&#x20;al.</ext-link> investigated the metabolic potential of <italic>Zymomonas mobilis</italic> for conversion of glucose and xylose to 2,3-butanediol. This study used calculated thermodynamic and kinetic parameters to generate insights of <italic>Z. mobilis</italic> metabolism. They also performed pathway and dynamic flux balance analysis to understand metabolic potential and production efficiency for future industrial applications. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2020.595552/full">Nitta et&#x20;al.</ext-link> acquired metabolomics and transcriptomics data on antibiotic producing strain, <italic>Streptomyces coelicolor</italic> to understand the functional connections between the production of antibiotic, actinorhodin and the level of cAMP. They found that higher levels of cAMP improved cell growth and production of actinorhodin, which was confirmed by the metabolomic and transcriptomic&#x20;data.</p>
<p>We conclude by emphasizing that high-throughput multi-omics data play a critical role to unravel the complexities of metabolic engineering to improve production efficiency and product titer produced by a variety of industrial microbes. In addition, generation of multi-omics datasets accelerates the adoption and subsequent application of artificial intelligence approaches such as machine learning to design of improved microbial bioproduction host systems (<xref ref-type="bibr" rid="B3">Lawson et&#x20;al., 2021</xref>). In terms of technological perspectives, enhanced high-throughput measurement and improved coverage of multi-omics analyses with higher accuracy will not only benefit in shortened DBTL cycle times for the metabolic engineering process, but also will lead to improved fundamental understanding of engineered biosystems. Refining tools and analytical platforms will benefit manipulating, modifying, and reshaping potential host systems. The long-term outcomes of these efforts will impact the world and our future by decarbonizing the current manufacturing processes <italic>via</italic> an environmental-friendly manner.</p>
</body>
<back>
<sec id="s1">
<title>Author Contributions</title>
<p>Y-MK, CP, EK, and SB served as co-editors for the Research Topic: Multi-omics technologies for optimizing synthetic biomanufacturing. Y-MK conceived of the idea for the research topic, and all the authors contributed to writing the editorial.</p>
</sec>
<sec id="s2">
<title>Funding</title>
<p>The work was supported by Agile BioFoundry (<ext-link ext-link-type="uri" xlink:href="http://agilebiofoundry.org">http://agilebiofoundry.org</ext-link>), funded by the United&#x20;States Department of Energy, Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office, under Award No. DE-NL0030038. Pacific Northwest National Laboratory (PNNL) is operated for the U.S. Department of Energy by Battelle Memorial Institute under contract DE-AC05-76RL01830.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clomburg</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Crumbley</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Industrial Biomanufacturing: The Future of Chemical Production</article-title>. <source>Science</source> <volume>355</volume>, <fpage>aag0804</fpage>. <pub-id pub-id-type="doi">10.1126/science.aag0804</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Karoui</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoyos-Flight</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Future Trends in Synthetic Biology-A Report</article-title>. <source>Front. Bioeng. Biotechnol.</source> <volume>7</volume>, <fpage>175</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2019.00175</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawson</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Mart&#xed;</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Radivojevic</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jonnalagadda</surname>
<given-names>S. V. R.</given-names>
</name>
<name>
<surname>Gentz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hillson</surname>
<given-names>N. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Machine Learning for Metabolic Engineering: A Review</article-title>. <source>Metab. Eng.</source> <volume>63</volume>, <fpage>34</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2020.10.005</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>